Tivic Health Systems

Tivic Health Systems Equity

The The Equity of Tivic Health Systems (TIVC) as of Nov 1, 2026 is 16.80 M USD. In the previous year, The Equity was 2.54 M USD — a change of 562.60% (higher).

Equity

16.80 MUSD

YoY

562.60%

Last updated:

In 2025, Tivic Health Systems's equity was 16.80 M USD, a 562.60% increase from the 2.54 M USD equity in the previous year.

The Tivic Health Systems Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
2.37 M USD
Jan 1, 2020
-1.18 M USD
Jan 1, 2021
13.27 M USD
Jan 1, 2022
3.63 M USD
Jan 1, 2023
3.58 M USD
Jan 1, 2024
2.54 M USD
Jan 1, 2025
16.80 M USD
The Tivic Health Systems Equity history
YEAREquityYoY
16.80 MUSD+562.60%
2.54 MUSD-29.19%
3.58 MUSD-1.38%
3.63 MUSD-72.65%
13.27 MUSD-1,227.61%
-1.18 MUSD-149.64%
2.37 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tivic Health Systems Stock analysis

What does Tivic Health Systems do? Tivic Health Systems Inc is a commercial-stage health tech company advancing bioelectronic medicine with patented technology that stimulates trigeminal, sympathetic, and vagus nerve structures. Its first commercial product, ClearUP, is an FDA-approved handheld bioelectronic sinus device clinically proven and doctor-recommended for treating inflammatory chronic conditions. ClearUP is sold directly to consumers in the U.S. through online retailers and commercial distributors, with reseller channels expanding its market reach. The company focuses on expanding its intellectual property portfolio and research programs related to vagus nerve stimulation for broader therapeutic applications. ClearUP serves consumers seeking drug-free therapeutic solutions for sinus conditions, targeting individuals with inflammatory chronic health issues who prefer non-invasive treatments. Healthcare providers recommend ClearUP as a safe, low-risk alternative to medication, appealing to patients looking for high safety profiles in treatment options. The company's revenue streams derive from direct consumer sales and reseller partnerships, leveraging its FDA approval and clinical validation to drive market adoption. Tivic Health Systems develops its products around non-invasive nerve stimulation technology, with ClearUP being the primary revenue-generating product. The company's strategy centers on expanding its IP portfolio to support future product development in bioelectronic medicine, particularly in vagus nerve stimulation applications. By focusing on clinical validation and doctor recommendations, Tivic Health aims to position itself as a leader in drug-free therapeutic solutions for chronic inflammatory conditions. Tivic Health Systems is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Tivic Health Systems's Equity

Tivic Health Systems's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Tivic Health Systems's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Tivic Health Systems's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Tivic Health Systems's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Tivic Health Systems’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Tivic Health Systems stock

The Equity of Tivic Health Systems is 16.80 M USD in 2025.

The Equity of Tivic Health Systems changed from 2.54 M USD to 16.80 M USD, representing a 562.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Tivic Health Systems since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Tivic Health Systems historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Tivic Health Systems

All Key Metrics — Tivic Health Systems